MeSH D008586 - pneumococcal meningitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Vancomycin | Vancomycin |  | 2015-12-23 |  |  |
| Mylan | Vancomycin | Vancomycin |  | 2008-12-30 |  |  |
| Lupin Research | Vancomycin | Vancomycin |  | 2015-01-28 |  |  |
| Sandoz | Vancomycin | Vancomycin |  | 2010-04-27 |  |  |
| Alkem Laboratories | Vancomycin | Vancomycin |  | 2022-11-14 |  |  |
| Hospira | Vancomycin | Vancomycin |  | 1988-08-04 |  |  |
| Amneal Pharmaceuticals | Vancomycin | Vancomycin |  | 2023-06-23 |  |  |
| Strides Pharma Global | Vancomycin | Vancomycin |  | 2012-04-09 |  |  |
| Lederle Laboratories | Vancomycin | Vancoled |  | 1993-10-15 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/1
Phase 3
100%2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use